PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)
PROCEPT BioRobotics' (PRCT) quarterly Preferred Stock Liabilities came in at $328.6 million in Q2 2021, up 34.74% on a QoQ basis from $243.9 million in Q1 2021.
PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 2 years of Preferred Stock Liabilities data on file, last reported at $328.6 million in Q2 2021.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $328.6 million in Q2 2021; TTM through Jun 2021 was $328.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $243.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q2 2021 stood at $328.6 million, up from $243.9 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for PRCT reached as high as $328.6 million in Q2 2021 and fell as low as $243.9 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | PROCEPT BioRobotics | 1.00 Bn | 757.43 Mn | 53.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 328.56 Mn |
| Mar 31, 2021 | 243.85 Mn |
| Dec 31, 2020 | 243.85 Mn |
| Sep 30, 2020 | 243.85 Mn |